Vijaya Diagnostic Centre Limited

NSEI:VIJAYA Stock Report

Market Cap: ₹70.8b

Vijaya Diagnostic Centre Past Earnings Performance

Past criteria checks 5/6

Vijaya Diagnostic Centre has been growing earnings at an average annual rate of 9.9%, while the Healthcare industry saw earnings growing at 29.7% annually. Revenues have been growing at an average rate of 9.8% per year. Vijaya Diagnostic Centre's return on equity is 19%, and it has net margins of 22%.

Key information

9.9%

Earnings growth rate

9.9%

EPS growth rate

Healthcare Industry Growth29.4%
Revenue growth rate9.8%
Return on equity19.0%
Net Margin22.0%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Vijaya Diagnostic Centre Limited (NSE:VIJAYA) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Feb 09
Vijaya Diagnostic Centre Limited (NSE:VIJAYA) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Vijaya Diagnostic Centre (NSE:VIJAYA) Hasn't Managed To Accelerate Its Returns

Dec 21
Vijaya Diagnostic Centre (NSE:VIJAYA) Hasn't Managed To Accelerate Its Returns

Vijaya Diagnostic Centre (NSE:VIJAYA) Ticks All The Boxes When It Comes To Earnings Growth

Nov 11
Vijaya Diagnostic Centre (NSE:VIJAYA) Ticks All The Boxes When It Comes To Earnings Growth

Returns On Capital At Vijaya Diagnostic Centre (NSE:VIJAYA) Paint A Concerning Picture

Feb 25
Returns On Capital At Vijaya Diagnostic Centre (NSE:VIJAYA) Paint A Concerning Picture

Vijaya Diagnostic Centre (NSE:VIJAYA) Knows How To Allocate Capital

Oct 14
Vijaya Diagnostic Centre (NSE:VIJAYA) Knows How To Allocate Capital

Vijaya Diagnostic Centre Limited (NSE:VIJAYA) Shares Could Be 27% Above Their Intrinsic Value Estimate

Aug 02
Vijaya Diagnostic Centre Limited (NSE:VIJAYA) Shares Could Be 27% Above Their Intrinsic Value Estimate

We Think That There Are Issues Underlying Vijaya Diagnostic Centre's (NSE:VIJAYA) Earnings

Jun 04
We Think That There Are Issues Underlying Vijaya Diagnostic Centre's (NSE:VIJAYA) Earnings

Analysts Have Lowered Expectations For Vijaya Diagnostic Centre Limited (NSE:VIJAYA) After Its Latest Results

Jun 01
Analysts Have Lowered Expectations For Vijaya Diagnostic Centre Limited (NSE:VIJAYA) After Its Latest Results

More Unpleasant Surprises Could Be In Store For Vijaya Diagnostic Centre Limited's (NSE:VIJAYA) Shares After Tumbling 27%

Feb 24
More Unpleasant Surprises Could Be In Store For Vijaya Diagnostic Centre Limited's (NSE:VIJAYA) Shares After Tumbling 27%

A Look At The Fair Value Of Vijaya Diagnostic Centre Limited (NSE:VIJAYA)

Feb 15
A Look At The Fair Value Of Vijaya Diagnostic Centre Limited (NSE:VIJAYA)

Revenue & Expenses Breakdown
Beta

How Vijaya Diagnostic Centre makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NSEI:VIJAYA Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 235,1361,1299140
30 Sep 234,9401,0348810
30 Jun 234,7599347990
31 Mar 234,5928468470
31 Dec 224,5448098340
30 Sep 224,5218988190
30 Jun 224,4409427400
31 Mar 224,6241,0977590
31 Dec 214,5821,1727080
30 Sep 214,4731,1666770
30 Jun 214,1701,0316420
31 Mar 213,7678456160
31 Mar 203,3886256930
31 Mar 192,9264596080

Quality Earnings: VIJAYA has high quality earnings.

Growing Profit Margin: VIJAYA's current net profit margins (22%) are higher than last year (17.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: VIJAYA's earnings have grown by 9.9% per year over the past 5 years.

Accelerating Growth: VIJAYA's earnings growth over the past year (39.6%) exceeds its 5-year average (9.9% per year).

Earnings vs Industry: VIJAYA earnings growth over the past year (39.6%) exceeded the Healthcare industry 29.5%.


Return on Equity

High ROE: VIJAYA's Return on Equity (19%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.